Towa Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	39,552	45,471	29,650	24,257	32,830	22,915
Short-Term Investments	267	-	-	-	-	-
Cash & Short-Term Investments	39,819	45,471	29,650	24,257	32,830	22,915
Cash Growth	36.12%	53.36%	22.23%	-26.11%	43.27%	22.45%
Receivables	81,091	71,631	71,657	54,392	50,748	45,784
Inventory	120,780	108,287	101,072	92,927	72,701	60,951
Other Current Assets	22,884	21,917	15,339	11,414	10,585	7,640
Total Current Assets	264,574	247,306	217,718	182,990	166,864	137,290
Property, Plant & Equipment	171,273	168,423	153,642	127,004	100,857	85,898
Long-Term Investments	1,004	3,213	3,006	3,104	3,035	3,277
Goodwill	25,356	28,115	32,568	34,613	44,647	7,050
Other Intangible Assets	17,398	17,727	18,018	18,332	9,455	7,913
Long-Term Deferred Tax Assets	-	6,037	5,699	5,303	5,075	4,239
Other Long-Term Assets	9,281	2	2	1	2	1
Total Assets	488,886	470,823	430,653	371,347	329,935	245,668
Accounts Payable	19,168	30,041	26,372	36,070	29,076	23,168
Accrued Expenses	-	112	96	117	108	100
Short-Term Debt	5,664	10,057	6,927	15,224	52,762	3,486
Current Portion of Long-Term Debt	24,852	18,023	10,120	7,527	12,172	7,181
Current Portion of Leases	1,666	1,383	-	-	-	-
Current Income Taxes Payable	3,049	20,334	23,911	14,012	15,536	12,069
Other Current Liabilities	38,926	7,989	12,692	5,579	5,419	5,512
Total Current Liabilities	93,325	87,939	80,118	78,529	115,073	51,516
Long-Term Debt	188,386	195,077	189,124	150,314	79,194	74,098
Long-Term Leases	13,090	11,801	-	-	-	-
Pension & Post-Retirement Benefits	159	141	220	322	547	540
Other Long-Term Liabilities	4,238	4,241	5,299	5,288	2,952	2,916
Total Liabilities	299,198	299,199	274,761	234,453	197,766	129,070
Common Stock	4,717	4,717	4,717	4,717	4,717	4,717
Additional Paid-In Capital	7,842	7,841	7,838	7,837	7,837	7,834
Retained Earnings	163,646	150,502	134,452	121,232	122,131	108,629
Treasury Stock	-5,584	-5,586	-5,606	-5,608	-5,608	-5,626
Comprehensive Income & Other	19,067	14,150	14,491	8,716	3,092	1,044
Shareholders' Equity	189,688	171,624	155,892	136,894	132,169	116,598
Total Liabilities & Equity	488,886	470,823	430,653	371,347	329,935	245,668
Total Debt	233,658	236,341	206,171	173,065	144,128	84,765
Net Cash (Debt)	-193,839	-190,870	-176,521	-148,808	-111,298	-61,850
Net Cash Per Share	-3937.59	-3877.50	-3586.33	-3023.21	-2211.60	-1206.18
Filing Date Shares Outstanding	49.23	49.23	49.22	49.22	49.22	49.21
Total Common Shares Outstanding	49.23	49.23	49.22	49.22	49.22	49.21
Working Capital	171,249	159,367	137,600	104,461	51,791	85,774
Book Value Per Share	3853.26	3486.37	3167.24	2781.16	2685.17	2369.18
Tangible Book Value	146,934	125,782	105,306	83,949	78,067	101,635
Tangible Book Value Per Share	2984.77	2555.14	2139.49	1705.52	1586.02	2065.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.